Search

everythinglearnresearchcommunity

for

Search:↓

Men with isolated hypogonadotropic hypogonadism have partial steroid deficiencies, while those with panhypopituitarism have severe deficiencies.

Dihydrotestosterone specifically binds to hamster sebaceous glands, with a higher affinity than testosterone.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Spironolactone treatment increases the amount of testosterone available in the body.

The assay effectively detects hormonal activity of certain chemicals.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

New treatments for male hypogonadism are effective and should be personalized.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Diane 35 plus finasteride is more effective for treating hirsutism.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Hidradenitis suppurativa improves with antiandrogen therapy.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.